Sara J Hyland, PharmD, BCCCP, FCCP, is a researcher and clinical pharmacist specializing in perioperative and emergency medicine. She dives into the intricacies of neuromuscular blockade reversal in the ICU, particularly the use of sugammadex versus traditional agents. The conversation highlights the challenges of underutilization, the importance of rigorous monitoring for patient safety, and the risks associated with sugammadex, including rare complications. Hyland emphasizes the need for better protocols and collaborative practices to optimize patient outcomes.
